[go: up one dir, main page]

GB9908921D0 - Spray dispenser for opiod antagonists - Google Patents

Spray dispenser for opiod antagonists

Info

Publication number
GB9908921D0
GB9908921D0 GBGB9908921.1A GB9908921A GB9908921D0 GB 9908921 D0 GB9908921 D0 GB 9908921D0 GB 9908921 A GB9908921 A GB 9908921A GB 9908921 D0 GB9908921 D0 GB 9908921D0
Authority
GB
United Kingdom
Prior art keywords
spray dispenser
opiod antagonists
opiod
antagonists
dispenser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9908921.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Priority to GBGB9908921.1A priority Critical patent/GB9908921D0/en
Publication of GB9908921D0 publication Critical patent/GB9908921D0/en
Priority to EP00925468A priority patent/EP1171099A1/en
Priority to PCT/GB2000/001509 priority patent/WO2000062757A1/en
Priority to JP2000611894A priority patent/JP2002541921A/en
Priority to GB0009622A priority patent/GB2349818A/en
Priority to AU44193/00A priority patent/AU4419300A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9908921.1A 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists Ceased GB9908921D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9908921.1A GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists
EP00925468A EP1171099A1 (en) 1999-04-19 2000-04-18 Composition containing opioid antagonists and spray dispenser
PCT/GB2000/001509 WO2000062757A1 (en) 1999-04-19 2000-04-18 Composition containing opioid antagonists and spray dispenser
JP2000611894A JP2002541921A (en) 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists
GB0009622A GB2349818A (en) 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists
AU44193/00A AU4419300A (en) 1999-04-19 2000-04-18 Composition containing opioid antagonists and spray dispenser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908921.1A GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists

Publications (1)

Publication Number Publication Date
GB9908921D0 true GB9908921D0 (en) 1999-06-16

Family

ID=10851820

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9908921.1A Ceased GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists
GB0009622A Withdrawn GB2349818A (en) 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0009622A Withdrawn GB2349818A (en) 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists

Country Status (5)

Country Link
EP (1) EP1171099A1 (en)
JP (1) JP2002541921A (en)
AU (1) AU4419300A (en)
GB (2) GB9908921D0 (en)
WO (1) WO2000062757A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
DE69738333T2 (en) 1997-10-01 2008-11-27 Novadel Pharma Inc. Non-polar spray for buccal administration
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
MXPA04008772A (en) * 2002-03-14 2004-12-06 Euro Celtique Sa Naltrexone hydrochloride compositions.
DE602004012403T2 (en) 2003-04-29 2009-03-19 Orexigen Therapeutics, Inc., La Jolla COMPOSITIONS FOR INFLUENCING LOSS OF WEIGHT
CN1726915B (en) * 2004-07-27 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 Nasal cavity drug delivery system and combination of naloxone hydrochloride and preparation method
PT2135603E (en) 2005-11-22 2013-04-03 Orexigen Therapeutics Inc COMPOSITIONS AND METHODS FOR INCREASING INSULIN SENSITIVITY
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20150082689A (en) 2006-11-09 2015-07-15 오렉시젠 세러퓨틱스 인크. Unit dosage packages
US20110144145A1 (en) 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
ES2762113T3 (en) 2010-01-11 2020-05-22 Nalpropion Pharmaceuticals Inc Methods of providing weight loss therapy in patients with major depression
IT1400067B1 (en) * 2010-05-21 2013-05-17 Molteni & C LIQUID NASAL SPRAY CONTAINING NALTREXONE WITH LOW DOSAGE.
NO2706982T3 (en) * 2011-05-13 2018-06-02
KR20200035501A (en) 2012-06-06 2020-04-03 오렉시젠 세러퓨틱스 인크. Methods of treating overweight and obesity
WO2015095644A1 (en) 2013-12-20 2015-06-25 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
DE112015001251T5 (en) * 2014-03-14 2017-01-19 Opiant Pharmaceuticals Inc. Nasal drug products and methods of use
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US20160008277A1 (en) * 2014-07-09 2016-01-14 Lightlake Therapeutics Inc. Co-packaged drug products
US20180092839A1 (en) * 2016-10-03 2018-04-05 Lance L. Gooberman Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
US20180110939A1 (en) * 2016-10-21 2018-04-26 Somniferum Labs LLC Method, system and apparatus for controlled delivery of opioid and other medications
CA3134943A1 (en) * 2019-03-26 2020-10-01 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
EP3946547A4 (en) 2019-03-26 2023-01-18 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US11484672B2 (en) * 2019-10-01 2022-11-01 Shareef J. Biltagi Opioid overdose treatment assembly
SMT202200411T1 (en) 2020-05-18 2022-11-18 Orexo Ab New pharmaceutical composition for drug delivery
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
MX2024006188A (en) 2021-11-25 2024-06-11 Orexo Ab NEW PHARMACEUTICAL COMPOSITION INCLUDING ADRENALINE.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
EP0245366A1 (en) * 1985-10-29 1987-11-19 Baker Cummins Pharmaceuticals, Inc. Method and composition for blocking antigen-induced allergic responses
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DE19536244A1 (en) * 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmaceutical compsn. for spraying as drops
PT1014943E (en) * 1997-02-05 2002-11-29 Jago Res Ag MEDICAL FORMULATIONS OF AEROSSOIS
DE69810355T2 (en) * 1997-12-03 2003-10-30 Britannia Pharmaceuticals Ltd., Redhill USE OF PHOSPHOLIPIDES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING ASTHMA

Also Published As

Publication number Publication date
EP1171099A1 (en) 2002-01-16
GB0009622D0 (en) 2000-06-07
GB2349818A (en) 2000-11-15
AU4419300A (en) 2000-11-02
WO2000062757A1 (en) 2000-10-26
JP2002541921A (en) 2002-12-10

Similar Documents

Publication Publication Date Title
GB9908921D0 (en) Spray dispenser for opiod antagonists
IL134219A0 (en) Spray dispenser
GB2354999B (en) Dispenser
AU142234S (en) Aerosol dispenser
AU9317101A (en) Aerosol spray dispenser
AU141718S (en) Sprayer
AU141721S (en) Dispenser head
AU140442S (en) Dispenser
AU140425S (en) Dispenser
GB9819981D0 (en) Spray dispenser
AU140586S (en) Dispenser
AU2957999A (en) Detergent for spray
AU141579S (en) Dispenser
GB2363573B (en) Atomising nozzle
GB9924844D0 (en) Dispenser
AU140706S (en) Dispenser
AU143284S (en) Dispenser
GB9906552D0 (en) Metering dispenser
IL129884A0 (en) Spray dispenser
GB9926143D0 (en) Spray technology improvement
GB0024003D0 (en) Spray dispenser
TW420047U (en) Improved structure for spray nozzle
AU139570S (en) Dispensing nozzle
TW478408U (en) Structure improvement for spraying nozzle
GB9913031D0 (en) Releasable atomisers for spraying devices

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)